Smruthi Organics informs about receipt of CEP certificate

09 Mar 2026 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Smruthi Organics has informed that the Company has received a Certificate of Suitability (CEP) from the European Directorate for the Quality of Medicines & HealthCare (EDQM), Europe for its product Amlodipine Besilate. The CEP certifies that the quality of the substance complies with the requirements of the European Pharmacopoeia and enables the Company to supply this product to pharmaceutical manufacturers in European markets and other regions that recognize the CEP certification. This milestone strengthens the Company’s regulatory portfolio and enhances opportunities to expand its presence in regulated markets.

The above information is a part of company’s filings submitted to BSE.

Smruthi Organics Share Price

118.10 -4.55 (-3.71%)
09-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1807.60
Dr. Reddys Lab 1286.40
Cipla 1325.15
Zydus Lifesciences 908.65
Lupin 2301.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×